11-a-Hydroxy Canrenone Methyl Ester (A2) CAS NO.192704-56-6

Send Inquiry
11-a-Hydroxy Canrenone Methyl Ester (A2) CAS NO.192704-56-6
Details
11A- hydroxycanlidone methyl acrylate is an ester organic matter, which is an intermediate in the preparation of eplenone.
Category
Eplerenone Intermediates
Share to
Description

11-a-Hydroxy canrenone methyl ester Basic information

Product Name:

11-a-Hydroxy canrenone methyl ester

Synonyms:

11-a-Hydroxycanrenonemethylester;11-ALPHA-HYDROXY-7-ALPHA-(METHOXYCARBONYL)-3-OXOPREGN-4-ENE-21,17-ALPHA-CARBOLACTONE;(7α,11α,17α)-11,17-Dihydroxy-3-oxopregn-4-ene-7,21-dicarboxylicAcidγ-LactoChemicalbookneMethylEster;11α,17β-Dihydroxypregn-4-en-3-one7α,21-dicarboxylicAcidγ-LactoneMethylEster;11α-HydroxyMexrenone;11α-HydroxyMexrenone;11-Alpha-Hydroxycanrenonemethylester;EplerenoneintermediateA2

CAS:

192704-56-6

MF:

C24H32O6

MW:

416.51

11-a-Hydroxy canrenone methyl ester Chemical Properties

 

Boiling point

604.5±55.0 °C(Predicted)

density

1.27±0.1 g/cm3(Predicted)

Storage conditions Sealed in dry,Room Temperature

pka

14.40±0.70(Predicted)

 

11-a-Hydroxy canrenone methyl ester is an eplerenone impurity

Eplerenone

Indications: Used for primary hypertension and heart failure after myocardial infarction. For severe hypertension that cannot be controlled by combining multiple antihypertensive drugs, the addition of eplerenone can significantly reduce blood pressure, especially the systolic blood pressure. Combined treatment with angiotensin converting enzyme inhibitory factor (ACEI) and β-blocker can improve the quality of life and reduce mortality of patients with severe heart failure and myocardial infarction.

A good medicine for treating high blood pressure has a protective effect on the liver, heart, and kidneys without damaging the organs. This medicine can promote urination without losing potassium.

Pharmacological effects:

EPL is a selective aldosterone receptor antagonist, it only acts on mineralocorticoid receptors, not on androgen and progesterone receptors. EPL treatment of patients with hypertension in stage 1 and stage 2 is similar to enalapril in the effectiveness and reduction of systolic and diastolic blood pressure. EPL also has a good antihypertensive effect in patients with essential hypertension with low renin levels and angiotensin-converting enzyme inhibitors and angiotensin receptor inhibitors. It also has a good antihypertensive effect on simple systolic hypertension, and has a good antihypertensive effect on diet-related obesity-related hypertension. In addition, EPL can significantly reduce the glomerular ultrafiltration effect, can reduce the albuminuria of hypertensive patients, for hypertensive patients with diabetes, this renal protection effect is more obvious

efficacy:

1. Congestive heart failure after acute myocardial infarction: Eplerenone can improve the quality of life of patients with left ventricular dysfunction (ejection fraction ≤40%), clinical trials have shown that this product can also be used for heart failure after acute myocardial infarction Congestive heart failure after acute myocardial infarction;

2. Antihypertensive: Eplerenone can be used alone or in combination with other antihypertensive drugs for the treatment of hypertension.

Hot Tags: 11-a-hydroxy canrenone methyl ester (a2) cas no.192704-56-6, China, manufacturers, suppliers, factory, custom, wholesale, CAS NO 192569 17 8, 11 alpha Hydroxycarvenone

Send Inquiry